RMC5127
RMC5127 is a brain-penetrant, oral inhibitor selectively targeting the KRAS G12V mutation. It blocks oncogenic RAS signaling, triggering apoptosis in mutant cells, and demonstrates antitumor efficacy in both cellular and animal models of KRAS G12V-driven cancers.
Product Specifications
CAS Number
3056146-38-1
Product Name Alternative
RMC-5127, RMC 5127
Field of Research
Cell Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
97.54% (May vary between batches)
Solubility
DMSO:100 mg/mL (94.13 mM)
Smiles
C[C@H] (OC) C (N=C1) =[C@@] ([C@@]2=C (CC (C) (C) COC ([C@H]3NN (C ([C@@H] (NC ([C@H]4OC[C@@H]4C) =O) [C@H]5N6CC7 (COC7) C6) =O) C8CC3C8) =O) C9=C (C=CC (C%10=CSC5=N%10) =C9) N2CCOC%11CCOCC%11) C=C1N%12CCN (C%13CC%13) CC%12
Molecular Formula
C57H75N9O9S
Molecular Weight
1062.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15291693 1 Vial
Lentiviral mouse Spink1 shRNA (UAS) - Lentiviral mouse Spink1 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 
A13989-1-Dylight594 100 µg
Anti-IQCE Antibody Picoband®, Dylight594 Conjugate
Sign In for Pricing
View Details